Alternative Protein Market (2026-2036)

The growth of this market is mainly driven by rising protein fortification demand across sports, clinical and healthy-ageing nutrition, the expansion of aquafeed, poultry and pet food as commercially viable end markets for non-conventional proteins, the scaling of biomass fermentation to commercial tonnage, growing soy and wheat protein capacity across Asia-Pacific, and the progressive authorisation of novel sources under the European novel food framework. However, the contraction of the plant-based meat category, the insolvency of several leading venture-funded insect protein producers, loss-making economics across dedicated plant protein businesses inside major ingredient groups, the pre-commercial scale of gas fermentation, and the difficulty of competing with soy on price restrain the growth of this market.

Furthermore, protein isolates for clinical and sports nutrition, biomass fermentation at commercial tonnage, black soldier fly protein for aquafeed and pet food, algae protein for nutraceuticals, and novel food authorisation as a route to premium positioning are expected to offer growth opportunities for the stakeholders in this market. However, high capital intensity per tonne of installed fermentation and insect capacity, the requirement to find value for starch and other co-product fractions, dependence on co-location and feedstock integration to reach commercial cost, and the limited number of authorised novel food sources remain major challenges impacting the growth of this market. Additionally, the migration of demand toward high-concentration isolates, the growth of aquafeed and pet food as primary end markets, the consolidation of insect protein production, and the progressive authorisation of microbial and insect sources are prominent trends in this market.

The Alternative Protein Market comprises protein ingredients derived from plants, microorganisms and insects, measured as supplier revenue at the point of sale into manufacturing. The market includes soy protein flours, concentrates, isolates and textured forms, vital wheat gluten and wheat protein isolates and hydrolysates, pea protein isolates, concentrates, textured forms and flours, canola, potato, rice and corn protein, algae protein including spirulina and chlorella, filamentous fungal biomass and mycoprotein, yeast protein and extracts, bacterial and gas-fermented protein, and insect protein meals. Protein concentrations range from flours below 65% protein through concentrates of 65% to 80% to isolates above 80%, with soy isolates commonly reaching 90% or above on a dry basis. Finished consumer products, conventional dairy, whey, casein, egg and gelatin proteins, fishmeal and rendered animal proteins, cultivated meat, and the starch, oil, fibre and frass co-products generated alongside protein are excluded. The market ecosystem extends from growers of soybeans, wheat, yellow peas, canola, potatoes and rice to oilseed and grain processors, specialty protein manufacturers operating dedicated fractionation assets, fermentation and insect producers, and the food, beverage, nutrition, aquafeed and pet food manufacturers that formulate with these ingredients.

The market is experiencing steady growth as protein fortification demand expands across sports, clinical and healthy-ageing nutrition and as aquafeed, poultry and pet food establish themselves as the end markets in which non-conventional proteins are commercially viable. Unit values range from below USD 2 per kilogram for commodity soy flours and textured proteins, through USD 2 to USD 5 per kilogram for soy and wheat concentrates and isolates, to between USD 5 and USD 12 per kilogram for pea and specialty isolates, and above that level for algae and fermented biomass. Plant protein accounted for approximately USD 17.00 billion of market value in 2025, supplied principally into bakery, nutrition, beverages, aquafeed and pet food applications. Increasing investments in fractionation capacity, fermentation capability and high-concentration isolates are significantly increasing demand across the market.

Supplier economics differ considerably by protein source, which is further shaping market growth. In soy and wheat protein, raw material accounts for 55% to 70% of cost, and the value realised on oil, starch and feed co-products determines delivered protein cost, allowing protein from an integrated crush complex to be produced more cheaply than protein from a standalone plant. In pea protein, the starch fraction represents approximately two-thirds of the bean by mass and must find a market of its own. In fermentation, feedstock and the energy required to run and cool the vessel dominate cost, and volumetric productivity is the governing performance metric. In insect production, feedstock cost is very low while capital intensity per tonne of installed capacity is high. ADM reported 2025 Nutrition segment revenues of USD 7,512 million, up 2%, within total revenues of USD 80,269 million, while the Ingredion segment holding its plant-based protein and protein fortification business reported net sales of USD 468 million with an operating loss of USD 2 million.

Demand across the plant-based meat application has contracted, while ingredient demand has proved considerably more resilient. Beyond Meat reported 2025 net revenues of USD 275.5 million, down 15.6%, on volume of 58.9 million pounds, down 15.9%, with gross profit of USD 7.6 million at a 2.8% margin against USD 41.7 million and 12.8% in 2024, and an operating loss of USD 332.7 million. Because protein ingredient content represents a small fraction of the retail value of a finished meat analogue, and because soy protein concentrate, isolate and vital wheat gluten are sold into bakery, nutrition, beverages, aquafeed and pet food in volumes well above meat analogue demand, ingredient offtake declined far less than brand revenue. ADM reported Human Nutrition operating profit of USD 319 million, down 2%, while Ingredion reported net sales of USD 7,219 million, down 3%, with Texture and Healthful Solutions net sales of USD 2,397 million, up 1%.

Another major growth driver is the scaling of biomass fermentation to commercial tonnage. ENOUGH operates approximately 10,000 tonnes per year of fungal biomass on a single line at Sas van Gent using fermentable sugars supplied from an adjacent Cargill starch facility, with a planned expansion to 20,000 tonnes, while Solar Foods reached full output at Factory 01 at a design capacity of 160 tonnes per year, rising to 230 tonnes in 2026. Insect protein production has consolidated sharply over the same period, with total capital committed to the sector reaching USD 88.45 million in 2025, Ynsect entering judicial liquidation in December 2025 after raising more than USD 500 million, ENORM of Denmark declared bankrupt in November, Inseco of South Africa ceasing operations, and Aspire Food Group entering receivership with assets sold under a court-approved transaction in September. Innovafeed has drawn cumulative funding above USD 500 million, raised a further EUR 51 million, and targets profitability at its Nesle facility by the end of 2027.

At the same time, the progressive authorisation of novel sources is reshaping the alternative protein ecosystem and creating new opportunities for suppliers able to complete the approval process. Four insect species are currently authorised as novel foods in the European Union, with five further applications under evaluation by the European Food Safety Authority, and Regulation (EU) 2025/89 of 20 January 2025 authorised ultraviolet-treated powder of Tenebrio molitor larvae. Market volume is expected to grow at 5.5% against value growth of 6.3%, with tonnage growth supplied principally by commodity soy and wheat protein serving aquafeed, pet food and bakery, and the additional value growth supplied by the migration toward isolates for clinical and sports nutrition and by microbial biomass sold at premium prices. Co-location and feedstock integration, and not process technology alone, are increasingly determining which capacity reaches commercial cost.

This reflects fortification rather than meat substitution as the source of growth in this market.

This indicates that co-location with feedstock rather than technology determines whether capacity reaches commercial cost.

This points to protein as a nutritional claim growing while protein as a meat replacement does not.